Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2013
11/19/2013US8586722 Methods of using tubers having genetically modified potato plant cells
11/19/2013US8586717 Method for the diagnosis and prognosis of malignant diseases
11/19/2013US8586716 EPHB3-specific antibody and uses thereof
11/19/2013US8586715 Humanized anti-CD4 antibody with immunosuppressive properties
11/19/2013US8586714 Dual variable domain immunoglobulins and uses thereof
11/19/2013US8586713 Readily isolated bispecific antibodies with native immunoglobulin format
11/19/2013US8586712 Humanized antibodies
11/19/2013US8586707 Stapled peptides and method of synthesis
11/19/2013US8586570 Sox-based kinase sensor
11/19/2013US8586538 Method of treating a patient suffering from a bleeding disorder comprising administering an antibody against the A3-C1 of FVIII
11/19/2013US8586531 Erythropoietin immunoglobulin fusion proteins
11/19/2013US8586317 Methods of diagnosing hypophosphatemic disorders
11/19/2013US8586052 Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells
11/19/2013US8586049 Antibody-drug conjugates
11/19/2013US8586048 G-CSF immunoglobulin fusion proteins
11/19/2013US8586047 Genetic products differentially expressed in tumors and the use thereof
11/19/2013US8586046 Methods and compositions for mycoplasma pneumoniae exotoxins
11/19/2013US8586045 Methods of using anti-CGRP antagonist antibodies
11/19/2013US8586044 Treatment of chronic pelvic pain syndrome
11/19/2013US8586043 Methods for treating breast cancer with inhibitors of neurotensin activation of NTSR1
11/19/2013US8586042 Hybridomas producing monoclonal anti-mortalin peptide antibodies
11/19/2013US8586041 Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
11/19/2013US8586039 Degraded TPO agonist antibody
11/19/2013US8586038 Chimeric immunoglobulin fusion proteins
11/19/2013US8586037 Antibodies against IL-17BR
11/19/2013US8586034 Cytomegalovirus disintegrin-like peptides
11/19/2013US8586033 Integrin αIIbβ3 specific antibodies and peptides
11/19/2013CA2604608C Antibody directed against gastrin-releasing peptide precursor and use thereof
11/19/2013CA2552823C Antibody purification
11/19/2013CA2502636C Diagnosis of shwachman-diamond syndrome
11/19/2013CA2500596C Anti-tsg101 antibodies and their uses for treatment of viral infections
11/19/2013CA2473987C Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
11/19/2013CA2447139C Specific binding proteins and uses thereof
11/19/2013CA2442684C Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
11/19/2013CA2398083C Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses
11/19/2013CA2383217C Lysosomal targeting pathway enzymes
11/19/2013CA2329757C Use of .alpha.1.beta.1 integrin receptor inhibitors and tgf-.beta.1 inhibitors in the treatment of kidney disease
11/14/2013WO2013170168A1 Multi-specific monoclonal antibodies
11/14/2013WO2013170139A1 Novel ha binding agents
11/14/2013WO2013169886A1 Anti-pcsk9 antibodies and use thereof
11/14/2013WO2013169734A1 Anti-erythropoietin antibodies
11/14/2013WO2013169693A1 Methods of treating cancer using an il-21 polypeptide and an anti-pd-1 antibody
11/14/2013WO2013169691A1 Anti-b7-h6 antibody, fusion proteins, and methods of using the same
11/14/2013WO2013169657A1 Methods for preventing biofilm formation
11/14/2013WO2013169625A1 Antibodies specific for cll-1
11/14/2013WO2013169532A1 Anti-c-met antibodies
11/14/2013WO2013169264A1 Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r)
11/14/2013WO2013168918A1 Anti-erbb2 antibody variants
11/14/2013WO2013168829A1 Anti oncostatin m receptor beta antibody
11/14/2013WO2013168820A1 Anti-cxadr antibody
11/14/2013WO2013168174A1 Apoe4 antibodies for treatment of neurodegenerative conditions
11/14/2013WO2013168150A1 Method of generating human monoclonal antibodies
11/14/2013WO2013167883A1 Single domain binding molecule
11/14/2013WO2013167720A1 Crystallization methods for purification of monoclonal antibodies
11/14/2013WO2013167681A1 CONFORMATIONAL-SPECIFIC ANTIBODIES AGAINST Αβ OLIGOMERS
11/14/2013WO2013167669A1 Antibodies capable of binding to the coagulation factor xi and/or its activated form factor xia and uses thereof
11/14/2013WO2013167259A1 Antibodies against claudin 18.2 useful in cancer diagnosis
11/14/2013WO2013167153A1 Antibodies useful in cancer diagnosis
11/14/2013WO2013167130A1 177-Lu LABELED PEPTIDE FOR SITE-SPECIFIC uPAR-TARGETING
11/14/2013WO2013166604A1 Single-arm monovalent antibody constructs and uses thereof
11/14/2013WO2013166594A1 Heteromultimer constructs of immunoglobulin heavy chains with mutations in the fc domain
11/14/2013WO2013144345A3 Toll-like receptor 2 binding epitope and binding members thereto
11/14/2013WO2013142300A3 Jcv neutralizing antibodies
11/14/2013WO2013142182A3 Combination therapy of a mek inhibitor and igf1r inhibitor
11/14/2013WO2013109856A3 Methods of using fgf19 modulators
11/14/2013WO2013088259A3 Methods of purifying antibodies
11/14/2013WO2013081463A3 Influenza a virus specific antibodies
11/14/2013WO2012116317A3 Combination therapies comprising anti-erbb3 agents
11/14/2013WO2012106669A3 Foxc1 antibodies and methods of their use
11/14/2013WO2003006605A9 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
11/14/2013WO2002063031A9 80091, a novel human ubiquitin carboxy-terminal hydrolase family member and uses thereof
11/14/2013US20130303735 Method of treating a pathological syndrome and a pharmaceutical agent
11/14/2013US20130303734 Novel homogeneous humanized antiproliferation antibodies
11/14/2013US20130303733 Multispecific Antibody Targeting and Multivalency Through Modular Recognition Domains
11/14/2013US20130303732 Method for using light scattering in real time to directly monitor and control impurity removal in purification processes
11/14/2013US20130303406 Engineering of immunoglobulin domains
11/14/2013US20130303399 Express humanization of antibodies
11/14/2013US20130302836 Common light chain mouse
11/14/2013US20130302399 Anti-pcsk9 antibodies and use thereof
11/14/2013US20130302357 Novel benzodiazepine derivatives
11/14/2013US20130302355 Novel modulators and methods of use
11/14/2013US20130302354 Alpha-4-beta-7 heterodimer specific antagonist antibody
11/14/2013US20130302353 Antibodies against a proliferating inducing ligand (april)
11/14/2013US20130302350 Human cytomegalovirus neutralizing antibodies and use thereof
11/14/2013US20130302349 Novel ha binding agents
11/14/2013US20130302348 Agents for influenza neutralization
11/14/2013US20130302347 Novel receptor-ligand interaction and uses thereof
11/14/2013US20130302346 Antibodies that bind notum pectinacetylesterase
11/14/2013US20130302341 Therapeutic and diagnostic applications targeting tnk-1
11/14/2013US20130302340 Human timp-1 antibodies
11/14/2013US20130302339 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and or wnt
11/14/2013US20130302338 Dermatophagoid pteronyssinus (der p1) antigen epitope and anti-der p1 antibody
11/14/2013US20130302336 Disulfide stabilized dvd-ig molecules
11/14/2013US20130302335 Ligands that bind tgf-beta receptor ii
11/14/2013US20130302332 Method for treating inflammation
11/14/2013US20130302330 Chimeric antigens for eliciting an immune response
11/14/2013US20130302326 Pyro-glutamate abeta targeting agents
11/14/2013US20130302325 Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
11/14/2013US20130302322 Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r)
11/14/2013US20130302320 Use of Semaphorin-4D Binding Molecules to Promote Neurogenesis Following Stroke
1 ... 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 ... 1494